Literature DB >> 27358274

Residual lifetime risk of chronic kidney disease.

Gearoid M McMahon1,2, Shih-Jen Hwang1, Caroline S Fox1,3.   

Abstract

BACKGROUND: An accurate estimation of the lifetime risk of chronic kidney disease (CKD) can aid in patient education while also informing the development of public health screening programs and educational campaigns.
METHODS: Framingham Offspring Study participants were included if they were free of CKD (estimated glomerular filtration rate <60 mL/min/1.73 m2) at age 50 years and had at least two serum creatinine measures during follow-up (mean 16 years, 49 506 person-years). We estimated the lifetime risk of CKD to age 90 years adjusting for the competing risk of death in the overall cohort and in population subgroups with known CKD risk factors including hypertension, obesity and diabetes.
RESULTS: Overall 3362 individuals (52% women) were included in the study. Mean age at study baseline was 54 years. By the end of the study, 729 individuals (21.7%) developed CKD and 618 (18.4%) died. At age 50 years, the cumulative lifetime risk of CKD was 41.3% [95% confidence interval (CI) 38.5-44.0]. The risk was increased in those with risk factors at baseline including diabetes (52.6%, 95% CI 44.8-60.4), hypertension (50.2%, 95% CI 46.1-54.3) and obesity (46.5%, 95% CI 41.1-52.0). For those individuals without any risk factors at baseline, the lifetime risk of CKD was lower (34.2%, 95% CI 29.4-39.0) relative to those with 1, 2 or 3 risk factors (45.0, 51.5 and 56.1% respectively, P < 0.01 for all compared with those with no risk factors).
CONCLUSIONS: Four out of 10 individuals without CKD at age 50 years will eventually develop CKD. This risk is modified by the presence of hypertension, diabetes and obesity at baseline. This demonstrates the importance of early identification of CKD risk factors, to aid in patient education, and potentially to reduce the future risk of disease. Published by Oxford University Press on behalf of ERA-EDTA 2016. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  body mass index; chronic renal insufficiency; diabetes mellitus; epidemiology; hypertension

Mesh:

Year:  2017        PMID: 27358274     DOI: 10.1093/ndt/gfw253

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Evolution and Kidney Development: A Rosetta Stone for Nephrology.

Authors:  Robert L Chevalier
Journal:  J Am Soc Nephrol       Date:  2018-02-15       Impact factor: 10.121

2.  Use of estimated glomerular filtration rate to predict incident chronic kidney disease in patients at risk of cardiovascular disease: a retrospective study.

Authors:  Saif Al-Shamsi; Abderrahim Oulhaj; Dybesh Regmi; Romona D Govender
Journal:  BMC Nephrol       Date:  2019-08-20       Impact factor: 2.388

3.  Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals.

Authors:  Ruiqi Zhang; Jil Billy Mamza; Tamsin Morris; George Godfrey; Folkert W Asselbergs; Spiros Denaxas; Harry Hemingway; Amitava Banerjee
Journal:  BMC Med       Date:  2022-02-07       Impact factor: 11.150

4.  Processing speed is affected by early impairment in kidney function in the general elder population.

Authors:  Tomas Månsson; Sölve Elmståhl
Journal:  BMC Nephrol       Date:  2021-09-21       Impact factor: 2.388

5.  Atorvastatin attenuates p‑cresyl sulfate‑induced atherogenesis and plaque instability in ApoE knockout mice.

Authors:  Hui Han; Yanjia Chen; Jinzhou Zhu; Jingwei Ni; Jiateng Sun; Ruiyan Zhang
Journal:  Mol Med Rep       Date:  2016-08-12       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.